Taylor Swift Problems: Rethinking Innovation in Medicine
I’ve been thinking about Taylor Swift - not for the usual reasons, but in the context of medical innovation.
10th February 2025We are all living longer but not necessarily living well. With an ageing population and almost all (90%) of us aged 45 years and older set to develop at least one chronic disease in our lifetime, the need for treatments that offer new solutions is essential.
At Istesso we are looking at chronic disease differently, focusing on repairing the damage caused by debilitating chronic conditions rather than symptom control. We are leading the field of tissue repair research, a currently untapped area that has the potential to fundamentally change the treatment paradigm for chronic disease and significantly improve patients’ lives. Our unique investigational treatments that repair, rebuild and restore damaged tissue, harness the body’s natural adaptive repair mechanisms, offering people the possibility of living disease free.
At Istesso, we believe in a future where chronic diseases can be healed, not just managed, and where the possibility of a disease-free life becomes a reality. Our ambitious, repair-first approach places the body’s innate repair mechanisms at the heart of our approach. We are unapologetic and unafraid to challenge conventional thinking as we execute on our mission to reshape the future by moving us from disease management to disease resolution.
"It’s hard to imagine anything more rewarding than translating exciting science into treatments with the potential to benefit patients."
I’ve been thinking about Taylor Swift - not for the usual reasons, but in the context of medical innovation.
10th February 2025CEO Lisa Patel wants to invite patients to the table and put their everyday experiences of living with chronic diseases at the forefront of future drug development.
16th October 2023CEO Lisa Patel wants to invite patients to the table and put their everyday experiences of living with chronic diseases at the forefront of future drug development.
17th August 2023